Omada Health, Inc. (OMDA)
NASDAQ: OMDA · Real-Time Price · USD
14.59
-0.13 (-0.88%)
At close: Apr 28, 2026, 4:00 PM EDT
14.87
+0.28 (1.89%)
After-hours: Apr 28, 2026, 4:12 PM EDT
Omada Health Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for Omada Health stock have an average target of 21.73, with a low estimate of 15 and a high estimate of 30. The average target predicts an increase of 48.94% from the current stock price of 14.59.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Omada Health stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 5 | 5 | 5 | 5 | 5 | 6 |
| Hold | 1 | 1 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 10 | 10 | 10 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citizens | Citizens | Buy Initiates $18 | Buy | Initiates | $18 | +23.37% | Apr 14, 2026 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $26 → $23 | Strong Buy | Maintains | $26 → $23 | +57.64% | Apr 9, 2026 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $20 → $15 | Buy | Maintains | $20 → $15 | +2.81% | Apr 8, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $32 → $26 | Buy | Maintains | $32 → $26 | +78.20% | Mar 12, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $28 → $22 | Strong Buy | Maintains | $28 → $22 | +50.79% | Mar 6, 2026 |
Financial Forecast
Revenue This Year
325.17M
from 260.21M
Increased by 24.96%
Revenue Next Year
390.45M
from 325.17M
Increased by 20.08%
EPS This Year
0.06
from -0.35
EPS Next Year
0.24
from 0.06
Increased by 302.21%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 339.2M | 412.3M | |||
| Avg | 325.2M | 390.5M | |||
| Low | 310.0M | 367.1M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 30.3% | 26.8% | |||
| Avg | 25.0% | 20.1% | |||
| Low | 19.1% | 12.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.23 | 0.47 | |
| Avg | 0.06 | 0.24 | |
| Low | -0.19 | -0.07 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | 676.3% | |
| Avg | - | 302.2% | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.